Hosted on MSN
AstraZeneca CEO says Summit drug could drive next generation of cancer combinations after $2 billion investment
AstraZeneca CEO Pascal Soriot told CNBC that Summit Therapeutics' lead drug could help power next-generation cancer combinations that could be the "future of cancer care." Soriot spoke exclusively ...
CNBC’s Annika Kim Constantino and Pascal Soriot, AstraZeneca CEO, join 'The Exchange' to discuss its $50 billion investment in stateside manufacturing and opening an research and development site in ...
Monday - Friday, 08:00 - 11:00 CET | 14:00 - 17:00 HK/SIN Pascal Soriot, CEO of British pharmaceutical giant AstraZeneca, discusses the company's $2.5 billion investment in a new China research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results